date,title,source
Oct-17-18,5 Beaten-Down Biotech Stocks to Pick Up from the Wreckage,InvestorPlace
Oct-17-18,"Report: Exploring Fundamental Drivers Behind Bellicum Pharmaceuticals, Social Reality, Exelixis, Edgewell Personal Care, Cronos Group, and Acacia Communications  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-18-18,"Exelixis to Release Third Quarter 2018 Financial Results on Thursday, November 1, 2018",Business Wire
Oct-19-18,Why Merck's Latest Success Means Trouble for Exelixis Inc.,Motley Fool
Oct-22-18,Exelixis Announces Results from the Dose-Escalation Stage of the Phase 1b COSMIC-021 Study of Cabozantinib in Combination with Atezolizumab in Previously Untreated Advanced Renal Cell Carcinoma,Business Wire
Oct-26-18,Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Exelixis,ACCESSWIRE
Oct-30-18,Exelixis (EXEL) to Report Q3 Earnings: What's in Store?,Zacks
Oct-31-18,Today's Research Reports on Trending Tickers: Exelixis and Sage Therapeutics,ACCESSWIRE
Nov-01-18,Exelixis: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Exelixis Announces Third Quarter 2018 Financial Results and Provides Corporate Update,Business Wire
Nov-05-18,Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market,Motley Fool
Nov-05-18,Edited Transcript of EXEL earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-05-18,Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Exelixis,ACCESSWIRE
Nov-06-18,"Exelixis to Present at the Stifel 2018 Healthcare Conference on November 13, 2018",Business Wire
Nov-08-18,Can Exelixis (EXEL) Run Higher on Rising Earnings Estimates?,Zacks
Nov-12-18,Edited Transcript of EXEL earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-12-18,"Detailed Research: Economic Perspectives on Roku, Exelixis, Scientific Games, Boot Barn, Astronics, and AtriCure  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Nov-12-18,"Exelixis Revenues for Cabozantinib Continue to Grow, Clinical Development and Regulatory Progress",ACCESSWIRE
Nov-13-18,Edited Transcript of EXEL earnings conference call or presentation 1-Nov-18 9:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,"Drug Sales Up, Biotech Stocks Down, Here's a Profit Opportunity",ACCESSWIRE
Nov-14-18,Today's Research Reports on Trending Tickers: Exelixis and Agios Pharmaceuticals,ACCESSWIRE
Nov-15-18,"Exelixis, Ipsen Get EU Nod for Label Expansion of Cabometyx",Zacks
Nov-15-18,"The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results",Benzinga
Nov-19-18,"Health Care Digest: Chelsea Clinton's shout out, Verily shelves 'smart lens' for diabetes, an East Bay biotech's hunt for employees and more",American City Business Journals
Nov-20-18,Exelixis Announces Webcasts of Investor Conference Presentations in November,Business Wire
Nov-23-18,Sarepta Stock More Than Doubles This Year So Far: Here's Why,Zacks
Nov-26-18,Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss,Zacks
Nov-26-18,3 Top Growth Stocks to Buy Right Now,Motley Fool
Nov-26-18,Is Exelixis Incs (NASDAQ:EXEL) CEO Being Overpaid?,Simply Wall St.
Nov-29-18,Biotech's Tackling Major Issues You Should Know,ACCESSWIRE
Dec-03-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Exelixis,ACCESSWIRE
Dec-04-18,Why Exelixis (EXEL) Could Be Positioned for a Surge,Zacks
Dec-06-18,Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx,Zacks
Dec-06-18,Today's Research Reports on Trending Tickers: Conatus Pharmaceuticals and Exelixis,ACCESSWIRE
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-12-18,"Report: Developing Opportunities within Exelixis, Cintas, BGC Partners, FirstEnergy, Hologic, and Trevena  Future Expectations, Projections Moving into 2018",GlobeNewswire
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-14-18,5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride,Zacks
Dec-17-18,5 Excellent GARP Picks With Cheap PEG Ratio,Zacks
Dec-27-18,Alexion's (ALXN) Soliris Drives Growth Amid Pricing Pressure,Zacks
Dec-31-18,Biotech Companies in the News,ACCESSWIRE
Jan-04-19,Top 10 Stocks Under $20,Zacks
Jan-08-19,Is Exelixis (EXEL) Outperforming Other Medical Stocks This Year?,Zacks
Jan-08-19,Exelixis Collaborator Daiichi Sankyo Receives Regulatory Approval For MINNEBRO (Esaxerenone) Tablets for the Treatment of Hypertension in Japan,Business Wire
Jan-11-19,Exelixis (EXEL) Dips More Than Broader Markets: What You Should Know,Zacks
Jan-11-19,"How Many Insiders Sold Exelixis, Inc. (NASDAQ:EXEL) Shares?",Simply Wall St.
Jan-11-19,3 Biotech Stocks Bubbling Away,Investopedia
Jan-14-19,5 Reasons Why Investors Should Buy Exelixis (EXEL) in 2019,Zacks
Jan-14-19,Exelixis stock up more than 4% after FDA drug approval,MarketWatch
Jan-15-19,Heres your guide to the upcoming biotechnology takeover wave,MarketWatch
Jan-15-19,How an East Bay cancer fighter  once kicked to the curb by Big Pharma  picked up its 4th drug approval,American City Business Journals
Jan-15-19,Exelixis' Cabometyx Tablets Receive FDA Nod for Liver Cancer,Zacks
Jan-15-19,Today's Research Reports on Trending Tickers: Exelixis and Editas Medicine,ACCESSWIRE
Jan-17-19,Amgen's Postmenopausal Osteoporosis Drug Gets FDA Panel Nod,Zacks
Jan-18-19,Exelixis (EXEL) Stock Sinks As Market Gains: What You Should Know,Zacks
Jan-29-19,"Exelixis to Release Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 12, 2019",Business Wire
Feb-01-19,"Factors of Influence in 2019, Key Indicators and Opportunity within Exelixis, Varian Medical, DXC Technology, Bridgepoint Education, Armstrong World Industries, and Immunomedics  New Research Emphasizes Economic Growth",GlobeNewswire
Feb-05-19,Exelixis (EXEL) Earnings Expected to Grow: Should You Buy?,Zacks
Feb-06-19,"Heres What Exelixis, Inc.s (NASDAQ:EXEL) P/E Ratio Is Telling Us",Simply Wall St.
Feb-07-19,Exelixis (EXEL) to Report Q4 Earnings: What's in Store?,Zacks
Feb-07-19,"Exelixis to Present at the Guggenheim Healthcare Talks Idea Forum / Oncology Day 2019 on February 14, 2019",Business Wire
Feb-12-19,Exelixis: 4Q Earnings Snapshot,Associated Press
Feb-12-19,Exelixis (EXEL) Tops Q4 Earnings and Revenue Estimates,Zacks
Feb-12-19,Exelixis Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,Business Wire
Feb-13-19,Cramer's lightning round: These are the two pot stocks I'm recommending,CNBC
Feb-13-19,Exelixis Grabs 90% of First Place,Motley Fool
Feb-13-19,"Exelixis (EXEL) Earnings, Revenues Beat Estimates in Q4",Zacks
Feb-13-19,Exelixis Rises as Fourth-Quarter Earnings Beat Estimates,TheStreet.com
Feb-13-19,These 'Small Ball' Names Will Outperform the Market in 2019,TheStreet.com
Feb-13-19,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",Benzinga
Feb-13-19,Edited Transcript of EXEL earnings conference call or presentation 12-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Feb-14-19,Implied Volatility Surging for Exelixis (EXEL) Stock Options,Zacks
Feb-15-19,New Strong Sell Stocks for February 15th,Zacks
Feb-19-19,Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster,Motley Fool
Feb-22-19,"Exelixis Inc (EXEL) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Mar-05-19,Exelixis Announces Webcasts of Investor Conference Presentations in March,Business Wire
Mar-05-19,3 Best Biotech Bargain Stocks on the Market Right Now,Motley Fool
Mar-08-19,Exelixis (EXEL) Dips More Than Broader Markets: What You Should Know,Zacks
Mar-12-19,Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation,Zacks
Mar-13-19,5 Biotech Stocks to Keep an Eye on in 2019,GuruFocus.com
Mar-13-19,"Why Exelixis, Inc. (NASDAQ:EXEL) Is An Attractive Investment To Consider",Simply Wall St.
Mar-14-19,Exelixis (EXEL) Gains As Market Dips: What You Should Know,Zacks
Mar-14-19,How a biotech company navigated bay bureaucracy to set up a commuter ferry service,American City Business Journals
Mar-14-19,Why Is Exelixis (EXEL) Up 12.1% Since Last Earnings Report?,Zacks
Mar-18-19,"Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'",Benzinga
Mar-18-19,Signal Says Buy Options Insurance on This Biotech,Schaeffer's Investment Research
